Page 7 - Prime Editor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Prime Medicine (NYSE:PRME – Get Rating) and MiNK Therapeutics (NASDAQ:INKT – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Profitability This table compares Prime Medicine and MiNK Therapeutics’ […]

Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 63,212 shares of Prime Medicine stock in a transaction on Friday, May 19th. The shares were sold at an average price of $13.88, for a total value of $877,382.56. The sale was disclosed in a legal filing with the Securities & […]

Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 27,290 shares of the company’s stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $12.72, for a total transaction of $347,128.80. Following the completion of the sale, the insider now directly owns 10,958,925 […]

Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 157,952 shares of the company’s stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $12.74, for a total value of $2,012,308.48. Following the completion of the sale, the insider now owns […]

Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 27,290 shares of the company’s stock in a transaction that occurred on Friday, May 12th. The stock was sold at an average price of $12.72, for a total transaction of $347,128.80. Following the completion of the sale, the insider now directly […]